Furthermore, a transgenic mouse model with systemic MICA expression reported suppression of NKG2D-mediated anti-tumor immunity, whereas soluble MICA in the serum did not affect NKG2D expression in non-transgenic mice [43]. The gene discussed is KLRK1; the disease is neoplasm.